Old age is the single greatest risk factor for frailty and diseases ranging from cancer to Alzheimer's. My research contributes to the nascent field of gerotherapeutics, a term used to describe drugs that delay the onset of age-related decline. In particular, I study how small molecules that alter mitochondrial function elicit systemic health benefits. I also have a deep interest in the molecular basis of fitness. By understanding how exercise prevents disease I believe we can make medicines that do the same.

I work with an excellent team of scientists led by Navdeep Chandel at Northwestern University.

My doctoral studies at Yale focused on obesity and type II diabetes.

Here's a link to my CV.